#biomarker

Clinicians can utilize this information to better monitor their patients and improve CRC outcomes with evidence-based treatment solutions.

A new study proposes using circulating tumor DNA as a biomarker to guide chemotherapy treatment decisions for CRC patients.

Patients whose treatment was guided by measurement of tumor cells in the blood had improved survival outcomes.

The new cancer subtypes help better characterize a person’s tumor. The goal is to get the right drug to the right patient.

An Army veteran, retired firefighter and farmer, Jeff Meckstroth, 65, lives in Ohio. He has Stage IV metastatic non-small-cell lung cancer.

Known as a carbon nanotube, the implant can detect cancer-associated proteins and alert a devise outside the body.

Many older people have biomarkers indicative of a strong response to checkpoint inhibitors.

The ExoGrail test could help reduce the need for invasive biopsies.

A new study has found that a microRNA may help drive the transition from normal fallopian tube cells to cancer in the ovary.

A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable.

This could result in better identification of the people who could benefit from screening and early detection of pancreatic cancer.

Biomarker was not linked to response rates in two studies of Keytruda for lung cancer.